The Saudi Initiative for Asthma - 2019 Update: Guidelines for the diagnosis and management of asthma in adults and children
Mohamed S Al-Moamary1, Sami A Alhaider2, Abdullah A Alangari3, Mohammed O Al Ghobain1, Mohammed O Zeitouni4, Majdy M Idrees5, Abdullah F Alanazi1, Adel S Al-Harbi6, Abdullah A Yousef7, Hassan S Alorainy8, Mohamed S Al-Hajjaj9
1 Department of Medicine, College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia 2 Department of Pediatrics, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia 3 Department of Pediatrics, College of Medicine, King Saud University, Riyadh, Saudi Arabia 4 Department of Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia 5 Respiratory Division, Department of Medicine, Prince Sultan Military Medical City, Riyadh, Saudi Arabia 6 Department of Pediatrics, Prince Sultan Military Medical City, Riyadh, Saudi Arabia 7 Department of Pediatrics, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia 8 Department of Respiratory Care, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia 9 Department of Clinical Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates
Correspondence Address:
Prof. Mohamed S Al-Moamary Department of Medicine, College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh Saudi Arabia
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/atm.ATM_327_18
|
This is the fourth version of the updated guidelines for the diagnosis and management of asthma, developed by the Saudi Initiative for Asthma (SINA) group, a subsidiary of the Saudi Thoracic Society. The main objective of the SINA is to have guidelines that are up to date, simple to understand, and easy to use by healthcare workers dealing with asthma patients. To facilitate achieving the goals of asthma management, the SINA panel approach is mainly based on the assessment of symptom control and risk for both adults and children. The approach to asthma management is now more aligned for different age groups. The guidelines have focused more on personalized approaches reflecting better understanding of disease heterogeneity with integration of recommendations related to biologic agents, evidence-based updates on treatment, and role of immunotherapy in management. The medication appendix has also been updated with the addition of recent evidence, new indications for existing medication, and new medications. The guidelines are constructed based on the available evidence, local literature, and current situation at national and regional levels. There is also an emphasis on patient–doctor partnership in the management that also includes a self-management plan.
|